以马内利是什么意思
Anand Reddi | |
|---|---|
 | |
| Born | Maryland, US |
| Nationality | American |
| Education | University of Michigan, Ann Arbor, University of Colorado School of Medicine |
| Occupation(s) | Global health policy specialist, public health advocate, biotech executive |
| Known for | Advocacy in global HIV/AIDS treatment and health systems strengthening |
| Awards | Fulbright Scholar, American Medical Association Foundation Leadership Award |
Anand Reddi is a global health policy expert, public health advocate and biopharma executive. Reddi works on health system strengthening initiatives with a focus on global health, implementation science, health financing and public health advocacy.[1][2] A major focus of scholarship is global HIV scale-up including the President's Emergency Plan for AIDS Relief (PEPFAR).[3][4] Since 2014, his focus has shifted to public-private global health partnerships to support access to essential medicines between by the biopharma private sector.[5][6] He served on the board of directors of the AIDS Healthcare Foundation from 2009 to 2011 and was a founding member of the board of directors of the Bay Area Global Health Alliance.[7]
Early life and education
[edit]Reddi pursued his undergraduate studies at the University of Michigan, Ann Arbor and a medical degree at the University of Colorado School of Medicine.[8] He was a Fulbright Scholar to KwaZulu-Natal, South Africa, focusing on pediatric antiretroviral scale-up under the research mentorship of Hoosen Coovadia at the PEPFAR funded Sinikithemba HIV/AIDS clinic at McCord Zulu Hospital.[9]
Global Health
[edit]HIV implementation science
[edit]In the early 2000s it was uncertain if the provision of antiretroviral therapy in resource limited settings such as Southern Africa was feasible.[10] Reddi's research documented that antiretroviral therapy is effective despite the challenges of a resource limited setting.[11][12] These data were important in providing implementation experience for HIV scale-up initiatives advanced by PEPFAR and The Global Fund.[13][14]
U.S. HIV global health policy
[edit]In May 2009, the Obama administration's introduced a global health initiative that de-prioritized global HIV funding by prioritizing funding for maternal and child health programs.[15][16] Ezekiel Emanuel, the initiative's architect and a special advisor to President Obama on health policy, argued that PEPFAR "is not the best use of international health funding" and "fails to address many of the developing world's most serious health issues."[17][18] Reddi challenged Dr. Emanuel's position on PEPFAR by arguing maternal and child health need not be framed in opposition to PEPFAR.[19][20][21] Reddi and Archbishop Desmond Tutu alongside other HIV advocates rebutted Emanuel's arguments that resulted in the restoration of $366 million for antiretroviral scale-up to Uganda in 2010.[22][23] The opinion pieces in The Huffington Post, The New York Times and The Washington Post facilitated the movement to drive the Obama administrations' reversal on global HIV funding.[24][25]
HIV pre-exposure prophylaxis access
[edit]The AIDS Healthcare Foundation (AHF) launched a campaign against the Food and Drug Administration review of Truvada for use as a HIV Pre-exposure Prophylaxis (PrEP) drug.[26] Reddi resigned from the Board of Directors of AHF over their opposition to HIV PrEP writing: "AHF's media campaign against FDA review of PrEP is myopic, blinded by its determination to derail a promising new medication."[27] The resulting advocacy was validated by the 2015 decision by the World Health Organization to recommended that people at substantial risk of HIV infection should be offered tenofovir disoproxil fumarate (TDF)-based oral PrEP as an additional HIV prevention option.[28]
Reddi also advanced digital health tools to enhance patient access to PrEP including the development and launch of Gilead Sciences' PrEP Hub, a digital platform aimed at improving access and public health resources to HIV prevention.[29][30]
Human capital contracts
[edit]To address healthcare worker shortages in resource-limited settings, Reddi proposed using human capital contracts inspired by Nobel Prize in Economic Sciences winner Milton Friedman.[31][32] Under this model, an investor—such as a donor nation, foundation, or global health initiative—would fund a student's medical training in exchange for 10 years of service in government or NGO clinics within their home country. Medical licenses would be tied to this commitment, and a multilateral agreement could curb migration during the service period to address human capital flight or "brain drain".[33][34]
HIV Test & Treat implementation science
[edit]Reddi led a major HIV Test & Treat initiative in Shinyanga, Tanzania, partnering with Gilead Sciences, The Vatican, the Tanzanian government, and NGOs like Doctors with Africa CUAMM and Joep Lange's Amsterdam Institute of Global Health.[6][35] The project reached over 300,000 people through decentralized outreach, linking those testing positive to care. Between May 2017 and June 2019, 255,329 HIV tests were conducted, with a positivity rate of 1.2%.[36]
Basic science
[edit]Anand Reddi has made contributions to basic science research with a focus oncology and tissue engineering.[37] His research mentors include Martha Somerman, Roel Nusse, Len Herzenberg and Xiao-Jing Wang. The American Federation for Medical Research and Society for Clinical Investigation awarded Reddi the Edwin E. Osgood Award for his research on the molecular mechanisms of microRNAs involved in transforming growth factor beta skin squamous cell cancer tumor initiation and metastasis.[38]
Conflict of interest disclosure in U.S. medical education
[edit]Transparency about faculty-industry financial relationships has become an increasingly important aspect of professionalism in academic medicine.[39] While such disclosures are common in publications and professional meetings, they are often overlooked in the medical school setting. Anand Reddi explored the educational benefits of faculty disclosing conflicts of interest to students and led policy efforts to promote this practice. In 2011, he implemented a disclosure policy at the University of Colorado School of Medicine followed by a national initiative with the American Medical Association that resulted in the Liaison Committee on Medical Education encouraging all U.S. medical schools to adopt disclosure guidelines.[40][41]
Awards
[edit]Reddi received the Thomas Jefferson Award from the University of Colorado, the Atlantic Dialogues Emerging Leader Award, the American Medical Association Foundation Leadership Award and the Fulbright Scholarship to South Africa for his contributions in global health policy and HIV/AIDS treatment and advocacy.[42]
References
[edit]- ^ Banning-Lover, Rachel (2025-08-05). "How to make global universal healthcare a reality". The Guardian. ISSN 0261-3077. Retrieved 2025-08-05.
- ^ Liu, Richard (19 November 2020). "Atlantic Dialogues Talks 2020: Health Capacities as a New Power Instrument". The Atlantic Dialogues: Policy Center for the New South.
- ^ October 2011, Ivy Mungcal // 18 (2025-08-05). "Anand Reddi: PEPFAR at Risk Should Mitt Romney Become US President". Devex. Retrieved 2025-08-05.
{{cite web}}: CS1 maint: numeric names: authors list (link) - ^ "The Need For A New AIDS Strategy". Mic. 2025-08-05. Retrieved 2025-08-05.
- ^ Nuki, Paul; Townsley, Simon (18 July 2018). "HIV and Aids in Africa has a new adversary – God and big pharma". The Telegraph.
- ^ a b Ratcliffe, Rebecca (22 July 2018). "Biker nun on a mission to free Tanzania from grip of HIV". The Guardian.
- ^ "HR Strategy Forum (HRSF) - Speaking out on Social/Political issues: CHRO's role in working with CEO". hrstrategyforum.org. Retrieved 2025-08-05.
- ^ "Anand Reddi, Director of Hepion Pharmaceuticals Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934". UNITED STATES SECURITIES AND EXCHANGE COMMISSION.
- ^ Reddi, Anand; Leeper, Sarah C.; Grobler, Anneke C.; Geddes, Rosemary; France, K Holly; Dorse, Gillian L.; Vlok, Willem J.; Mntambo, Mbali; Thomas, Monty; Nixon, Kristy; Holst, Helga L.; Karim, Quarraisha Abdool; Rollins, Nigel C.; Coovadia, Hoosen M.; Giddy, Janet (17 March 2017). "Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa". BMC Pediatrics. 7 (12): 13. doi:10.1186/1471-2431-7-13. PMC 1847430. PMID 17367540.
- ^ Herbert, Bob (11 June 2001). "In America; Refusing To Save Africans". The New York Times.
- ^ Purvis, Katherine. "How do we increase the HIV response with limited funds?". The Guardian. Retrieved 6 July 2024.
- ^ Banning-Lover, Rachel. "What is the best model to bring healthcare to all?". The Guardian. Retrieved 19 June 2024.
- ^ Leeper, Sarah C.; Reddi, Anand (2025-08-05). "United States global health policy: HIV/AIDS, maternal and child health, and The President's Emergency Plan for AIDS Relief (PEPFAR)". AIDS. 24 (14): 2145–2149. doi:10.1097/QAD.0b013e32833cbb41. ISSN 0269-9370. PMID 20606571.
- ^ Judem, Emily. "An invisible issue: The presidential campaign and HIV/AIDS". The World Radio Program.
- ^ Bendavid, Eran; Miller, Grant (2025-08-05). "The US Global Health Initiative: Informing Policy With Evidence". JAMA. 304 (7): 791–792. doi:10.1001/jama.2010.1189. ISSN 0098-7484. PMC 3816172. PMID 20716743.
- ^ D'Almeida, Kanya. "Obama AIDS Plan Stumbles over Funding". Global Issues. Inter Press Service. Retrieved 19 June 2024.
- ^ "U.S. Global Health Policy: HIV/AIDS at a Crossroads Initial Accomplishments Threatened by Policy Changes". University of Colorado School of Medicine. CU Medicine Today. Retrieved 6 July 2024.
- ^ Denny, Colleen C.; Emanuel, Ezekiel J. (2025-08-05). "US Health Aid Beyond PEPFAR: The Mother & Child Campaign". JAMA. 300 (17): 2048–2051. doi:10.1001/jama.2008.556. ISSN 0098-7484. PMID 18984893.
- ^ "United States Global Health Policy: HIV/AIDS Treatment Funding At Risk Under President Obama". The Huffington Post. 21 June 2010.
- ^ Khan, Azmat (19 July 2012). "What Is President Obama's Track Record on HIV/AIDS?". Frontline (PBS).
- ^ Mungcal, Ivy (22 July 2010). "Eric Goosby, Bill Clinton Defend Obama's AIDS Funding Decisions". Devex.
- ^ Tutu, Desmond (2025-08-05). "Opinion | Obama's Overdue AIDS Bill". The New York Times. ISSN 0362-4331. Retrieved 2025-08-05.
- ^ Mungcal, Ivy (23 July 2010). "Obama Promises to Step Up AIDS Fight". Devex.
- ^ "Aids: Time to Refocus". The New York Times. 1 Nov 2010.
- ^ "AIDS/HIV funding must be a priority for the U.S." The Washington Post. 3 August 2010.
- ^ "AHF to Gilead: "No Magic Pill" Ads Warn against AIDS Drug as HIV Prevention". AIDS Healthcare Foundation. 9 March 2011.
- ^ "Moving Forward on FDA Review of HIV Prevention Drugs". The Huffington Post. 2 Nov 2011.
- ^ World Health Organization. "Pre-exposure prophylaxis (PrEP)". Global HIV Program: PrEP. Retrieved 12 June 2024.
- ^ "Pharma companies are capitalizing on Covid-19 restrictions to promote unbranded campaigns". Pharmaceutical Technology Review. Retrieved 23 July 2024.
- ^ Bulik, Beth Snyder (28 Oct 2020). "BI, Gilead execs highlight value of disease awareness campaigns—particularly during the pandemic". Fierce Pharma.
- ^ "Healthcare Reform: Solving the Medical Student Debt Crisis Through Human Capital Contracts". The Huffington Post.
- ^ Weinstein, Louis; Wolfe, Honor (1 July 2010). "A unique solution to solve the pending medical school tuition crisis". American Journal of Obstetrics and Gynecology. 203 (1): 19.e1–19.e3. doi:10.1016/j.ajog.2009.11.019. PMID 20035918.
- ^ "Global Health Service Corps Essential To Improve African Health Systems, Achieve 'AIDS-Free Generation'". Kaiser Family Foundation.
- ^ Reddi, A.; Thyssen, A.; Smith, D.; Lange, J. H.; Akileswaran, C. (2012). "Human capital contracts for global health: a plan to increase the number of physicians in resource limited settings". AIDS. 26 (15): 1979–1980. doi:10.1097/QAD.0b013e32835857d4. PMID 22992581.
- ^ Tanzania, World Health Organization. "The Tanzania Catholic Church launches the Test and Treat Project". WHO Tanzania. Retrieved 12 June 2024.
- ^ Martelli, Giulia; Van Duffel, Lukas; Kwezi, Edith Cosmas; Cavallin, Francesco; Salehe, Idd Amiri; Torelli, Giovanni F.; Putoto, Giovanni; Hermans, Sabine; Rinke De Wit, Tobias F.; Pozniak, Anton (2022). "Community- and facility-based HIV testing interventions in northern Tanzania: Midterm results of Test & Treat Project". PLOS ONE. 17 (4): e0266870. Bibcode:2022PLoSO..1766870M. doi:10.1371/journal.pone.0266870. PMC 9004748. PMID 35413074.
- ^ Reddi, Anand; Powers, Matthew A.; Dellavalle, Robert P. (2014). "Therapeutic potential of the anti-diabetic agent metformin in targeting the skin cancer stem cell diaspora". Experimental Dermatology. 23 (5): 345–346. doi:10.1111/exd.12349. ISSN 1600-0625. PMID 24521225.
- ^ White, Ruth A.; Neiman, Jill M.; Reddi, Anand; Han, Gangwen; Birlea, Stanca; Mitra, Doyel; Dionne, Laikuan; Fernandez, Pam; Murao, Kazutoshi; Bian, Li; Keysar, Stephen B.; Goldstein, Nathaniel B.; Song, Ningjing; Bornstein, Sophia; Han, Zheyi (2013). "Epithelial stem cell mutations that promote squamous cell carcinoma metastasis". The Journal of Clinical Investigation. 123 (10): 4390–4404. doi:10.1172/JCI65856. ISSN 1558-8238. PMC 3784525. PMID 23999427.
- ^ Austad, Kirsten E.; Kesselheim, Aaron S. (2025-08-05). "Conflict of interest disclosure in early education of medical students". JAMA. 306 (9): 991–992. doi:10.1001/jama.2011.1233. ISSN 1538-3598. PMID 21900140.
- ^ Reddi, Anand; Lowenstein, Steven R. (2012). "It's time for faculty to disclose their industry financial ties to medical students". Academic Medicine: Journal of the Association of American Medical Colleges. 87 (6): 682–683. doi:10.1097/ACM.0b013e31825375c2. ISSN 1938-808X. PMID 22643371.
- ^ Reddi, Anand (2013). "New guidelines for the disclosure of academic-industry financial ties and modeling professionalism during medical education". JAMA Pediatrics. 167 (12): 1091–1092. doi:10.1001/jamapediatrics.2013.3480. ISSN 2168-6211. PMID 24081013.
- ^ "Achievements in academics, service recognized with CU's 2013 Jefferson Award". University of Colorado. Retrieved 7 July 2024.
External links
[edit]